Ahmadi, S., Talbott, M., Reed, S., Gonzalez Sepulveda, J. M., Yang, J. C., Scheri, R., … Sosa, J. A. (2019). PSU37 QUANTIFYING BENEFIT-RISK TRADEOFFS FOR SURGICAL OPTIONS IN LOW-RISK THYROID CANCER. In Value in Health (Vol. 22, pp. S372–S372). Elsevier BV. https://doi.org/10.1016/j.jval.2019.04.1817

Ahmadi, S., M. Talbott, S. Reed, J. M. Gonzalez Sepulveda, J. C. Yang, R. Scheri, M. Stang, S. Roman, and J. A. Sosa. “PSU37 QUANTIFYING BENEFIT-RISK TRADEOFFS FOR SURGICAL OPTIONS IN LOW-RISK THYROID CANCER.” In Value in Health, 22:S372–S372. Elsevier BV, 2019. https://doi.org/10.1016/j.jval.2019.04.1817.

Ahmadi S, Talbott M, Reed S, Gonzalez Sepulveda JM, Yang JC, Scheri R, et al. PSU37 QUANTIFYING BENEFIT-RISK TRADEOFFS FOR SURGICAL OPTIONS IN LOW-RISK THYROID CANCER. In: Value in Health. Elsevier BV; 2019. p. S372–S372.

Ahmadi, S., et al. “PSU37 QUANTIFYING BENEFIT-RISK TRADEOFFS FOR SURGICAL OPTIONS IN LOW-RISK THYROID CANCER.” Value in Health, vol. 22, Elsevier BV, 2019, pp. S372–S372. Crossref, doi:10.1016/j.jval.2019.04.1817.

Ahmadi S, Talbott M, Reed S, Gonzalez Sepulveda JM, Yang JC, Scheri R, Stang M, Roman S, Sosa JA. PSU37 QUANTIFYING BENEFIT-RISK TRADEOFFS FOR SURGICAL OPTIONS IN LOW-RISK THYROID CANCER. Value in Health. Elsevier BV; 2019. p. S372–S372.